Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 1021 AL 1035

Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson's Disease Pathogenesis: A Narrative Review

Angelopoulou E, Paudel YN, Papageorgiou SG, Piperi C.

Brain Sci. 2022 Jan 28;12(2):175. doi: 10.3390/brainsci12020175.

Prodromal Cognitive Deficits and the Risk of Subsequent Parkinson's Disease

Speelberg DHB, Janssen Daalen JM, Bloem BR, Gagnon JF, Post B, Darweesh SKL.

Brain Sci. 2022 Jan 31;12(2):199. doi: 10.3390/brainsci12020199.

Caregiver Burden in Partners of Parkinsonian Patients with Deep Brain Stimulation

Gülke E, Pötter-Nerger M.

Brain Sci. 2022 Feb 9;12(2):238. doi: 10.3390/brainsci12020238.

Focused Ultrasound Stimulation as a Neuromodulatory Tool for Parkinson's Disease: A Scoping Review

Lee KS, Clennell B, Steward TGJ, Gialeli A, Cordero-Llana O, Whitcomb DJ.

Brain Sci. 2022 Feb 19;12(2):289. doi: 10.3390/brainsci12020289.

Molecular Mechanisms and Therapeutic Potential of α- and β-Asarone in the Treatment of Neurological Disorders

Balakrishnan R, Cho DY, Kim IS, Seol SH, Choi DK.

Antioxidants (Basel). 2022 Jan 29;11(2):281. doi: 10.3390/antiox11020281.

Neuroprotection against Aminochrome Neurotoxicity: Glutathione Transferase M2-2 and DT-Diaphorase

Segura-Aguilar J, Muñoz P, Inzunza J, Varshney M, Nalvarte I, Mannervik B.

Antioxidants (Basel). 2022 Jan 31;11(2):296. doi: 10.3390/antiox11020296.

CNS Redox Homeostasis and Dysfunction in Neurodegenerative Diseases

Goldsteins G, Hakosalo V, Jaronen M, Keuters MH, Lehtonen Š, Koistinaho J.

Antioxidants (Basel). 2022 Feb 16;11(2):405. doi: 10.3390/antiox11020405.

Passive Immunization in Alpha-Synuclein Preclinical Animal Models

Folke J, Ferreira N, Brudek T, Borghammer P, Van Den Berge N.

Biomolecules. 2022 Jan 20;12(2):168. doi: 10.3390/biom12020168.

The Key Role of GM1 Ganglioside in Parkinson's Disease

Chowdhury S, Ledeen R.

Biomolecules. 2022 Jan 21;12(2):173. doi: 10.3390/biom12020173.

Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson's Disease

Chagraoui A, Di Giovanni G, De Deurwaerdère P.

Biomolecules. 2022 Feb 1;12(2):243. doi: 10.3390/biom12020243.

Update on CSF Biomarkers in Parkinson's Disease

Kwon EH, Tennagels S, Gold R, Gerwert K, Beyer L, Tönges L.

Biomolecules. 2022 Feb 18;12(2):329. doi: 10.3390/biom12020329.

Are Cell-Based Therapies Safe and Effective in the Treatment of Neurodegenerative Diseases? A Systematic Review with Meta-Analysis

Van den Bos J, Ouaamari YE, Wouters K, Cools N, Wens I.

Biomolecules. 2022 Feb 21;12(2):340. doi: 10.3390/biom12020340.

Multiple Aspects of Inappropriate Action of Renin-Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases

Szczepanska-Sadowska E, Wsol A, Cudnoch-Jedrzejewska A, Czarzasta K, Żera T.

J Clin Med. 2022 Feb 9;11(4):908. doi: 10.3390/jcm11040908.

Gastrointestinal Dysfunction in Parkinson's Disease: Current and Potential Therapeutics

Han MN, Finkelstein DI, McQuade RM, Diwakarla S.

J Pers Med. 2022 Jan 21;12(2):144. doi: 10.3390/jpm12020144.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias